JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
77 hedge funds and large institutions have $80.2M invested in Jounce Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 29 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
-3
Holders Change %
-3.75%
% of All Funds
1.69%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
9
Increased
29
Reduced
22
Closed
12
Calls
$57K
Puts
–
Net Calls
+$57K
Net Calls Change
-$46K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$528K |
| 2 |
EIM
2
Essex Investment Management
Boston,
Massachusetts
|
$360K |
| 3 |
3
BlackRock
New York
|
$4.21M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$1.2M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$2.88M |
